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HIV-infected women in sub-Saharan Africa are at substantial risk of unintended pregnancy and sexually transmitted infections
(STIs). Linkages between HIV and reproductive health services are advocated. We describe implementation of a reproductive
health counseling intervention in 16 HIV clinics in Lusaka, Zambia. Between November 2009 and November 2010, 18,407 women
on antiretroviral treatment (ART) were counseled. The median age was 34.6 years (interquartile range (IQR): 29.9–39.7), and
60.1% of women were married. The median CD4+ cell count was 394cells/uL (IQR: 256–558). Of the women counseled, 10,904
(59.2%) reported current modern contraceptive use. Among contraceptive users, only 17.7% reported dual method use. After
counseling, 737 of 7,503 women not previously using modern contraception desired family planning referrals, and 61.6% of
these women successfully accessed services within 90 days. Unmet contraceptive need remains high among HIV-infected women.
Additional eﬀorts are needed to promote reproductive health, particularly dual method use.
1.Introduction
The Millennium Development Goals, adopted in New York
in 2000, promote universal education and gender equality,
maternal and child health, and prevention and treatment
for HIV/AIDS [1]. Provision of comprehensive reproductive
health care is central to attaining these goals [2]. Worldwide,
as many as one-third of the 357,000 annual maternal deaths
are attributable to unintended pregnancies; the majority
of these mortalities occur in low- and middle-income
countries [3–6]. Enhanced access to family planning services
in sub-Saharan Africa would result in marked reductions
in unintended pregnancies and unsafe abortions and a
projected 69% decrease in maternal deaths and a 57%
decrease in newborn deaths [4]. In addition to substantial
risks of dying from pregnancy complications [7], women in
a sub-Saharan Africa are also at increased risk of HIV and
other sexually transmitted infections [8, 9]. Providing safe,
eﬀective contraception to HIV-infected women who desire it
has also been identiﬁed by the World Health Organization as
aprimarystrategyforpreventionofpediatricinfections[10].
In Zambia, as in many other sub-Saharan African coun-
tries, HIV-infected women of childbearing age represent a
vulnerable population. The burden of STIs is high among
HIV-infected pregnant women in this setting [11]. Addi-
tionally, only 20–40% of HIV-infected Zambian couples,
whether serodiscordant or concordant, report use of a mod-
ern contraceptive method other than condoms [12, 13].
Public health programs that emphasize dual family planning
methods—highly eﬀective modern contraception coupled
with condom use—will ensure protection from both unin-
tended pregnancy, and STIs, and should form the corner-
stone of reproductive health care. In HIV care and treat-
ment programs, medication adherence counseling provides
a unique window of opportunity to address preventive
health recommendations, including family planning and STI
prevention. In this paper, we describe implementation of2 Infectious Diseases in Obstetrics and Gynecology
an integrated, reproductive health peer counselor program
in 16 public-sector HIV clinics in Lusaka, Zambia. We also
report (1) baseline modern contraceptive and dual method
use among HIV-infected women receiving antiretroviral
treatment, (2) uptake of modern contraceptive and dual
methods following peer counseling, and (3) predictors of
modern contraceptive and dual method use among HIV-
infected women.
2.MaterialsandMethods
Lusaka is home to almost 2 million people [14]. The HIV
prevalence rate among pregnant women is 21% [15], and the
majority of women infected with HIV are of reproductive
age. The Ministry of Health’s ART program was established
in 2004 and covers the entire city. Over 100,000 HIV-
infected individuals in Lusaka are now receiving care in
this system. Due to the large volumes of patients and
humanresourceshortages[16],peereducatorsconductmost
ART counseling sessions. Prior to our intervention, neither
routine family planning nor dual method counseling was
provided during peer counseling sessions. To expand the
scopeandeﬀectivenessofthesecounselingvisits,wedesigned
and implemented a reproductive health peer counselor
program integrated within 16 primary care HIV clinics in
Lusaka.
We trained 109 peer counselors to deliver a standardized
counseling message, emphasizing dual methods. The coun-
seling intervention was implemented within the context of
routine clinical care. With the aid of a printed counseling
tool, peer educators delivered a comprehensive reproductive
health message, including information on the range of
barrier methods, hormonal and intrauterine contraception,
and permanent sterilization. Women who desired access
to reproductive health services were referred to a separate,
on-site family planning department. In order to support
public-sector reproductive health service provision, we also
trained 42 family planning nurses. Training was based
on the national family planning curriculum and nurses
who successfully completed both a classroom-based course
and a mentored, clinical practicum-received certiﬁcation.
Public-sector family planning clinics provided condoms,
oral contraceptive pills (OCPs), depot medroxyprogesterone
acetate (DMPA), Jadelle levonorgestrel implants, and copper
intrauterine devices (IUDs). Women who wished to undergo
permanent sterilization were referred to a center with
surgical facilities, such as the University Teaching Hospital.
Our analysis cohort included HIV-infected women aged
16–50 years and on ART at one of the 16 intervention clinics.
To be eligible, a woman had to have at least one reproductive
health counseling visit documented in her medical record
between November 2009 and November 2010. We report
baseline sociodemographic data, CD4+ cell count (cells/uL),
hemoglobin level (g/dL), and history of tuberculosis. These
data were ascertained through review of women’s electronic
medical and laboratory records. Laboratory results were
assessed within 90 days of the woman’s counseling visit.
We also report use of modern contraception, including
dual method use. Peer counselors collected data relating
to reproductive health counseling and contraceptive use on
a clinical form developed for the project. We considered
condoms, OCPs, DMPA, Jadelle, IUDs, and sterilization as
modern contraception. Dual method use was deﬁned as
use of condoms to prevent STIs coupled with use of a
short- or long-term reversible contraceptive or sterilization.
Contraceptive use data were self-reported.
Univariate and multivariate regression analyses were
used to identify sociodemographic and other predictors
independently associated with modern contraceptive and
dual method use, as well as with access to family planning
services within 90 days of a counseling visit. Crude odds
ratios (ORs) and 95% conﬁdence intervals (CIs) were
computed using logistic regression models. Adjusted odds
ratios (AORs) and their corresponding 95% CIs were
generated using generalized estimating equations to account
for clustering at the site level. All statistical analyses were
performed using SAS version 9.1.3 (SAS Institute Inc, Cary,
NorthCarolina).Ethicalapprovalforthisstudywasobtained
from the University of Zambia Biomedical Research Ethics
Committee (Lusaka, Zambia) and the University of Alabama
at Birmingham Institutional Review Board (Birmingham,
AL, USA).
3. Results
Between November 2009 and November 2010, 32,998
women had a least one clinic visit at a site where the
counseling program had been implemented. Project staﬃng
levels had been calculated on an estimated 20,000 clinical
visitsduringtheone-yearimplementationperiod.Therefore,
for logistic reasons, not all women accessing HIV treatment
services at participating clinics received reproductive health
counseling.Overthestudyperiod,documentedreproductive
health counseling visits were available for 18,407 (55.8%)
HIV-infectedwomen.Baselinecharacteristicsofwomenwho
completed at least one counseling visit compared with those
who did not receive reproductive health counseling are
detailed in Table 1. With the exception of median CD4+ cell
count and median treatment duration, diﬀerences between
women who received the counseling intervention and those
who did not were not clinically signiﬁcant.
3.1. Cohort Description. Our analysis cohort included 18,407
HIV-infected women. At enrolment, the median age was
34.6 years (IQR: 29.9–39.7 years), 60.1% of women were
married, 87.4% had one or more living children, and
39.2% had completed some secondary education. 63.0%
of women reported their monthly income as ≥200,000
Zambian kwacha (approximately $45). The median CD4+
cell count was 394cells/uL (IQR: 256–558cells/uL), and
the median hemoglobin level was 12.4g/dL (IQR: 11.3–
13.4g/dL). The median time on ART was 709 days (IQR:
262–1,302 days). 3,441 (18.7%) women reported a history
of or current active tuberculosis infection. Less than half
(42.5%) of the women in our cohort had disclosed their
serostatus to a partner. Furthermore, most women (77.1%)
did not know or did not provide information about their
partner’s HIV status at the time of enrollment into care.Infectious Diseases in Obstetrics and Gynecology 3
Table 1: Baseline characteristics of HIV-infected women aged 16–50 years receiving antiretroviral treatment at 16 public-sector clinics in
Lusaka, Zambia (November 2009–November 2010).
Women with documented RH counseling Women with no documented RH counseling visit
P-value
N Value N Value
Age at 1st visit (years), median
(IQR) 18,407 34.6 (29.9–39.7) 14,591 34.7 (29.5–40.9) <0.001++
16–24 1,246 6.8% 1,263 8.7% <0.001∗∗
25–34 8,362 45.4% 6,232 42.7%
≥35 8,799 47.8% 7,096 48.6%
Marital status 14,180 11,135
Married 8,523 60.1% 6,570 59.0% 0.076∗∗
Single/divorced/widowed 5,657 39.9% 4,565 41.0%
Education 16,910 13,441
None 4,677 27.7% 3,785 28.2% 0.016∗∗
Primary 5,603 33.1% 4,246 31.6%
Secondary or more 6,630 39.2% 5,410 40.2%
Number of living children,
median (IQR) 14,385 2 (1–3) 11,373 2 (1–3) 0.061++
0 1,806 12.6% 1,505 13.2% 0.106∗∗
≥1 12,579 87.4% 9,868 86.8%
Monthly income 12,243 9,400
<ZMK 200,000 4,532 37.0% 3,864 41.1% <0.001∗∗
≥ZMK 200,000 7,711 63.0% 5,536 58.9%
CD4+ cell count (cells/uL),
median (IQR) 18,231 394 (256–558) 14,419 357 (228–522) <0.001++
<250 4,361 23.9% 4,187 29.0% <0.001∗∗
250–350 3,338 18.3% 2,819 19.6%
≥351 10,532 57.8% 7,413 51.4%
Hemoglobin (g/dL), median
(IQR) 18,175 12.4 (11.3–13.4) 14,248 12.2 (11.0–13.1) <0.001++
≤8.0 363 2.0% 482 3.4% <0.001∗∗
8.1–9.9 1,365 7.5% 1,276 9.0%
≥10.0 16,447 90.5% 12,490 87.7%
History or current tuberculosis 18,407 14,591
Yes 3,441 18.7% 2,771 19.0% 0.493∗∗
No 14,966 81.3% 11,820 81.0%
Time on ART (days), median
(IQR) 18,407 709 (262–1,302) 14,591 659 (245–1,180) <0.001++
HIV status disclosure to partner 18,407 14,591
Yes 7,823 42.5% 6,026 41.3% 0.028∗∗
Unknown 10,584 57.5% 8,565 58.7%
Partner’s HIV status 18,407 14,591
Negative 621 3.4% 456 3.1% <0.001∗∗
Positive 3,598 19.5% 2,599 17.8%
Unknown 5,332 29.0% 4,362 29.9%
Missing 8,856 48.1% 7,174 49.2%
RH: reproductive health; IQR: interquartile range; ZMK: Zambian Kwacha; ART: antiretroviral therapy.
∗∗Person’s chi-square test; ++Wilcoxon rank sum test.4 Infectious Diseases in Obstetrics and Gynecology
737
women desired
contraception following
counseling
454
women accessed a
contraceptive method within
90 days of counseling
283
women unable to access family
planning services
18,407
women
counseled about
reproductive health
7,503
women not using a
contraceptive method prior
to counseling
14,591
women not counseled about
reproductive health
10,904
women previously using a
contraceptive method:
8,018 condoms
1,079 DMPA
727 OCPs
584 levonorgestrel implant
373 IUD
123 sterilization
6,766
women declined referral to
family planning clinic
32,998
HIV + women
16–50 years old receiving
antiretroviral treatment at
Lusaka public-sector HIV
clinics
Figure 1: Description of the study cohort.
3.2.BaselineModern ContraceptiveandDualMethodUse. Of
the 18,407 women included in the analysis, 10,904 (59.2%)
reported current use of a modern contraceptive method:
73.5% of women reported condom use, 9.9% DMPA use,
6.7% OCP use, 5.4% levonorgestrel implant use, 3.4%
IUD use, and 1.1% had undergone permanent sterilization
(Figure 1). Among the 10,904 women who reported use of
a modern contraceptive method at their counseling visit,
1,927 (17.7%) stated that they used dual methods for both
pregnancy and STI prevention.
3.3. Impact of the Counseling Intervention and Unmet Con-
traceptive Need. Of the 7,503 (40.8%) women in our cohort
not using modern contraception, 737 (9.8%) women desired
contraception after counseling and 71 stated an intention to
use dual methods. 454 of 737 (61.6%) women who desired
contraception successfully accessed family planning services
within 90 days of their counseling visit. Our data, therefore,
indicate that nearly 40% of womenwho desired reproductive
health services were unable to access public-sector services
(i.e., free from point-of-service user fees). This represents
substantial unmet contraceptive need within Lusaka’s public
health system.
In univariate analysis, age was the only factor associated
with successful access to contraceptive services within 90
days of a counseling visit. In multivariate analysis, women
25–34 years (AOR: 0.53; 95% CI: 0.30–0.92) or ≥35 years
(AOR: 0.49; 95% CI: 0.25–1.00) had lower odds of accessing
contraceptiveservicesthanwomen16–24years.Womenwho
reported a higher monthly income also had lower odds
of accessing contraceptive services than women who were
less wealthy (AOR: 0.68; 95% CI: 0.47–0.98). By contrast,
multiparae were more likely to access reproductive health
services within 90 days than women with no living children
(AOR: 1.83; 95% CI: 1.17–2.88).
3.4. Predictors of Modern Contraceptive Use. In univariate
analysis, women were less likely to report modern contra-
ceptive use if ≥35 years, single, divorced, or widowed, with
undisclosed HIV status, and if their partner’s HIV status
was unknown (Table 2). Conversely, women 25–34 years
with one or more living children, those reporting higher
monthly incomes, those with CD4+ cell counts ≥250cells/uL
or hemoglobin levels ≥8.1g/dL, and those without a history
of tuberculosis infection had increased odds of contraceptive
use. In multivariate analysis, age, marital status, HIV status
disclosure, parity, CD4+ cell count, and hemoglobin level
remainedassociated withmodern contraceptiveuse.Women
≥35 years old (AOR: 0.63; 95% CI: 0.52–0.77), single,
divorced, or widowed women (AOR: 0.30; 95% CI: 0.27–
0.34), and those for whom HIV status disclosure was
unknown (AOR: 0.75; 95% CI: 0.64–0.87) had lower odds
of using modern contraception. The odds of using modern
contraception were higher among women with one or more
living children (AOR: 1.47; 95% CI: 1.21–1.78), and among
healthier women with CD4+ cell counts of 250–350cells/uL
(AOR:1.18;95%CI:1.05–1.33)or ≥351cells/uL(AOR:1.23;
95% CI: 1.10–1.38) than among nullipara and those with
low CD4+ cell counts. A similar association was observed for
hemoglobin levels 8.1–9.9g/dL (AOR: 1.56; 95% CI: 1.24–
1.97) and ≥10.0g/dL (AOR: 2.16; 95% CI: 1.72–2.71).
3.5. Predictors of Dual Method Use. In univariate analysis,
women who were ≥35 years, single, divorced, or widowed
and those who did not provide information regarding HIV
status disclosure had a lower odds of dual method use
(Table 3). Higher odds of dual method use were observed
among women with one or more living children, those
with CD4+ cell counts ≥351cells/uL, and those who did
not report a history of tuberculosis. In multivariate analysis,
women ≥35 years (AOR: 0.51; 95% CI: 0.41–0.63) were less
likely to report dual method use than those 16–24 years.
Women who were single, divorced, or widowed were also
less likely to use dual methods than married women (AOR:Infectious Diseases in Obstetrics and Gynecology 5
Table 2: Predictors of modern contraceptive use among HIV-infected women aged 16–50 years receiving antiretroviral treatment at 16
public-sector clinics in Lusaka, Zambia (November 2009–November 2010).
Women using modern
contraception
Women not using modern
contraception Crude OR (95% CI) Adjusted OR (95% CI)
N = 11,358 N = 7,049
Age at 1st visit (years)
16–24 736 (6.5%) 510 (7.2%) 1.00 1.00
25–34 5,747 (50.6%) 2,615 (37.1%) 1.52 (1.35–1.72) 1.05 (0.87–1.25)
≥35 4,875 (42.9%) 3,924 (55.7%) 0.86 (0.76–0.97) 0.63 (0.52–0.77)
Marital status
Married 6,503 (72.9%) 2,020 (38.4%) 1.00 1.00
Single/divorced/widowed 2,414 (27.1%) 3,243 (61.6%) 0.23 (0.22–0.25) 0.30 (0.27–0.34)
Education
None 2,862 (27.4%) 1,815 (28.2%) 1.00 1.00
Primary 3,493 (33.4%) 2,110 (32.7%) 1.05 (0.97–1.14) 1.13 (0.99–1.28)
Secondary or more 4,108 (39.3%) 2,522 (39.1%) 1.03 (0.96–1.12) 1.13 (1.00–1.27)
Number of living children
0 1,041 (11.6%) 765 (14.2%) 1.00 1.00
≥1 7,947 (88.4%) 4,632 (85.8%) 1.26 (1.14–1.39) 1.47 (1.21–1.78)
Monthly income
<ZMK 200,000 2,709 (35.9%) 1,823 (38.8%) 1.00 1.00
≥ZMK 200,000 4,835 (64.1%) 2,874 (61.2%) 1.13 (1.05–1.22) 1.03 (0.92–1.15)
CD4+ cell count (cells/uL)
<250 2,473 (22.0%) 1,887 (27.1%) 1.00 1.00
250–350 2,042 (18.1%) 1,295 (18.6%) 1.20 (1.10–1.32) 1.18 (1.05–1.33)
≥351 6,746 (59.9%) 3,784 (54.3%) 1.36 (1.27–1.46) 1.23 (1.10–1.38)
Hemoglobin (g/dL)
≤8.0 168 (1.5%) 195 (2.8%) 1.00 1.00
8.1–9.9 710 (6.3%) 655 (9.4%) 1.26 (1.00–1.59) 1.56 (1.24–1.97)
≥10.0 10,355 (92.2%) 6,090 (87.8%) 1.97 (1.60–2.43) 2.16 (1.72–2.71)
History or current tuberculosis
Yes 1,999 (17.6%) 1,442 (20.5%) 1.00 1.00
No 9,359 (82.4%) 5,607 (79.5%) 1.20 (1.12–1.30) 1.06 (0.96–1.18)
HIV status disclosure to partner
Yes 5,985 (52.7%) 1,838 (26.1%) 1.00 1.00
Unknown 5,373 (47.3%) 5,211 (73.9%) 0.32 (0.30–0.34) 0.75 (0.64–0.87)
Partner’s HIV status
Negative 476 (4.2%) 145 (2.1%) 1.00 1.00
Positive 2,700 (23.8%) 898 (12.7%) 0.92 (0.75–1.12) 0.76 (0.54–1.06)
Unknown 3,357 (29.6%) 1,975 (28.0%) 0.52 (0.43–0.63) 0.75 (0.56–0.99)
Missing 4,825 (42.5%) 4,031 (57.2%) 0.36 (0.30–0.44) 0.66 (0.48–0.89)
OR: odds ratio; 95% CI: 95% conﬁdence interval.
0.75; 95% CI: 0.66–0.86). Conversely, women with one or
more living children (AOR: 2.07; 95% CI: 1.59–2.70), those
with CD4+ cell counts ≥351cells/uL (AOR: 1.25; 95% CI:
1.09–1.45), and those with no prior history of tuberculosis
infection (AOR: 1.17; 95% CI: 1.01–1.35) had higher odds of
dual method use.
4. Discussion
We successfully implemented a peer-led counseling inter-
vention in ART clinics, focusing on dual family planning
method use to prevent unintended pregnancies and STIs.
Ourinitialprojectionswerethat20,000HIV-infectedwomen6 Infectious Diseases in Obstetrics and Gynecology
Table 3: Predictors of dual method use among HIV-infected women aged 16–50 years receiving antiretroviral treatment at 16 public-sector
clinics in Lusaka, Zambia (November 2009–November 2010).
Women using dual
methods
Women not using dual
methods Crude OR (95% CI) Adjusted OR (95% CI)
N = 2,247 N = 9,111
Age at 1st visit (years)
16–24 170 (7.6%) 566 (6.2%) 1.00 1.00
25–34 1,269 (56.5%) 4,478 (49.1%) 0.94 (0.79–1.13) 0.80 (0.62–1.04)
≥35 808 (36.0%) 4,067 (44.6%) 0.66 (0.55–0.80) 0.51 (0.41–0.63)
Marital status
Married 1,407 (77.9%) 5,096 (71.7%) 1.00 1.00
Single/divorced/widowed 400 (22.1%) 2,014 (28.3%) 0.72 (0.64–0.81) 0.75 (0.66–0.86)
Education
None 562 (27.0%) 2,300 (27.4%) 1.00 1.00
Primary 692 (33.2%) 2,801 (33.4%) 1.01 (0.89–1.14) 1.02 (0.86–1.21)
Secondary or more 830 (39.8%) 3,278 (39.1%) 1.04 (0.92–1.17) 1.06 (0.90–1.24)
Number of living children
0 154 (8.4%) 887 (12.4%) 1.00 1.00
≥1 1,685 (91.6%) 6,262 (87.6%) 1.55 (1.30–1.85) 2.07 (1.59–2.70)
Monthly income
<ZMK 200,000 538 (35.0%) 2,171 (36.1%) 1.00 1.00
≥ZMK 200,000 999 (65.0%) 3,836 (63.9%) 1.05 (0.93–1.18) 0.93 (0.82–1.07)
CD4+ cell count (cells/uL)
<250 438 (19.7%) 2,035 (22.5%) 1.00 1.00
250–350 394 (17.7%) 1,648 (18.2%) 1.11 (0.96–1.29) 1.05 (0.87–1.26)
≥351 1,397 (62.7%) 5,349 (59.2%) 1.21 (1.08–1.37) 1.25 (1.09–1.45)
Hemoglobin (g/dL)
≤8.0 28 (1.3%) 140 (1.6%) 1.00 1.00
8.1–9.9 120 (5.4%) 590 (6.5%) 1.02 (0.65–1.60) 1.01 (0.51–2.02)
≥10.0 2,076 (93.3%) 8,279 (91.9%) 1.25 (0.83–1.89) 1.31 (0.80–2.16)
History or current tuberculosis
Yes 333 (14.8%) 1,666 (18.3%) 1.00 1.00
No 1,914 (85.2%) 7,445 (81.7%) 1.29 (1.13–1.46) 1.17 (1.01–1.35)
HIV status disclosure to partner
Yes 1,291 (57.5%) 4,694 (51.5%) 1.00 1.00
Unknown 956 (42.5%) 4,417 (48.5%) 0.79 (0.72–0.86) 1.03 (0.85–1.25)
Partner’s HIV status
Negative 102 (4.5%) 374 (4.1%) 1.00 1.00
Positive 564 (25.1%) 2,136 (23.4%) 0.97 (0.76–1.23) 0.92 (0.69–1.22)
Unknown 721 (32.1%) 2,636 (28.9%) 1.00 (0.79–1.27) 1.03 (0.70–1.51)
Missing 860 (38.3%) 3,965 (43.5%) 0.80 (0.63–1.00) 0.89 (0.65–1.22)
OR: odds ratio; 95% CI: 95% conﬁdence interval.
would access care across the participating clinics during
the 12-month implementation period. Our team of peer
educators counseled 18,407 HIV-infected women enrolled
in care during this period, demonstrating the feasibility of
this approach in a low-resource, African setting. At their
baseline counseling visit, nearly 60% of women reported use
of a modern contraceptive method; the majority used solely
condoms. Among contraceptive users, only 26.5% reported
use of a highly eﬀective modern contraceptive method. Dual
method use was also low at 17.7%.
Older, single women with lower CD4+ cell counts
were less likely to be using modern contraception. These
ﬁndings highlight a vulnerable population of HIV-infected
women. As the health of women with lower CD4+ cell
counts improves on ART and as unmarried women enter
new sexual partnerships, both groups remain at risk forInfectious Diseases in Obstetrics and Gynecology 7
unintended pregnancy and STIs. Future reproductive health
policyandprogrammingshouldbeexpandedbeyondafocus
on married, healthy women [17].
We were disappointed at the low numbers of women
who desired access to family planning services and were
unable to obtain it in a timely fashion. We can only speculate
as to the reasons for this. In Lusaka, family planning
services are not integrated within HIV clinics, and most
family planning clinics are only open to patients in the
afternoons. A woman who has already spent much of her
morning in an ART clinic is less likely to return to spend
another half-day in a family planning clinic. Periodic stock-
outs of reproductive health commodities may also limit
women’s access to family planning services. Additionally, we
speculate that most messages in the community promote
condomuseoveruseofmoreeﬀectivemoderncontraception
or dual method use. Providers’ attitudes towards sexual
and reproductive healthcare for HIV-infected patients [18,
19] and misconceptions regarding the safety of hormonal
contraceptive methods among women on ART may also play
a role in limiting HIV-infected women’s access to family
planning [20].
The strengths of our study include the successful imple-
mentation of a standardized and comprehensive repro-
ductive health counseling intervention. This intervention
was acceptable to both providers and patients. Using a
peer educator model, we demonstrate that it is possible to
reach a sizeable number of HIV-infected women attending
public ART clinics. It also became evident through our
intervention that strengthening reproductive health care
requires stronger linkages between family planning clinics,
STI services, and HIV screening and treatment [21], as
well as improved community understanding. Our study had
several limitations. Contraceptive method and condom use
were self-reported and thus subject to bias. Additionally, we
did not assess the impact of our counseling intervention on
pregnancy rates.
This study conﬁrms the ﬁndings of smaller Zambian
clinical trials[12,22,23]anddemonstratesthat 40% ofHIV-
infected women on ART are not using any form of modern
contraception. Among contraceptive users, less than 30%
use highly eﬀective modern methods and even fewer use
dualmethods.Ourcounselinginterventionimproveduptake
of modern contraceptives and dual method use modestly.
Demographic and Health Surveys have demonstrated that
knowledge of modern contraception is high among Zam-
bians [24]. Additional quantitative and qualitative research
should address fertility desires and barriers to dual method
use in this population, guiding future public health interven-
tions. Male partner involvement through couples counseling
should be investigated further [25].
Our ﬁndings also underscore important challenges faced
byHIV-infectedwomenattemptingtoaccessfamilyplanning
services within the public health system. Unmet contra-
ceptive need is as high as 40% among these women.
Strengthening public-sector service provision, with the goal
of ensuring that no woman is turned away from a family
planning clinic empty handed, should be an urgent priority.
Finally, integrating family planning service provision into
HIV care and treatment clinics will likely improve access to
reproductive health services [26].
5. Conclusions
We successfully demonstrate the feasibility of integrating
comprehensive reproductive health counseling into HIV care
and treatment. We conﬁrm that nearly 60% of HIV-infected
women receiving care within the Zambian public-sector
r eportuseofamodernc ontrac epti v emethod.H o w ev er ,only
27% of these women use highly eﬀective hormonal or long-
term reversible methods, and even fewer women report dual
method use. Additional eﬀorts are needed to promote dual
method use, particularly among older, unmarried women
and those with more advanced HIV disease. These inter-
ventions should be coupled with health system changes that
address critical bottlenecks in reproductive health service
provision.
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